Found 11 matching trials
A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying PHASE2 Gastric emptying is the end-result of a complex and carefully regulated ser...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis PHASE2 GSK962040 is a novel small molecule motilin agonist. The Phase I studies (M...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis PHASE2 This study is a randomized, double-blind, placebo controlled trial designed...
Show More Location
GSK Investigational Site
Learn More & Join Trial
GSK962040 Drug-drug Interaction Study With Ketoconazole PHASE1 This study will determine the effect of 400 mg ketoconazole on the pharmaco...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance PHASE2 The aims of MOT112571 are to assess the pharmacodynamic effects, safety, to...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study PHASE2 This is a multi-center, parallel group, placebo-controlled and active-compa...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effect of GSK962040 on Oesophageal Function PHASE1 GSK962040 is a selective non-peptide motilin receptor agonist which is in d...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. PHASE1 This study will evaluate the safety, tolerability and exposure of repeat es...
Show More Location
GSK Investigational Site
Learn More & Join Trial
The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis PHASE2 The purpose of this study is to assess the pharmacodynamic effects (gastric...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 PHASE1 Motilin is a peptide whose action is controlled by motilin receptors locate...
Show More Location
GSK Investigational Site
Learn More & Join Trial